Detalhe da pesquisa
1.
Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III study.
J Endocrinol Invest
; 43(11): 1613-1622, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32385851
2.
[Diagnostics and treatment of acromegaly : Necessity for targeted monitoring of comorbidities]. / Diagnostik und Therapie der Akromegalie : Notwendigkeit der gezielten Überwachung von Komorbiditäten.
Internist (Berl)
; 58(11): 1171-1182, 2017 Nov.
Artigo
Alemão
| MEDLINE | ID: mdl-29027568
3.
Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma.
Clin Endocrinol (Oxf)
; 82(1): 106-14, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24923438
4.
Extended treatment of Cushing's disease with pasireotide: results from a 2-year, Phase II study.
Pituitary
; 17(4): 320-6, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23943009
5.
Increased prevalence of anxiety-associated personality traits in patients with Cushing's disease: a cross-sectional study.
Neuroendocrinology
; 97(2): 139-45, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-22572774
6.
Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency.
Clin Endocrinol (Oxf)
; 76(1): 88-95, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21682757
7.
Cognitive function in acromegaly: description and brain volumetric correlates.
Pituitary
; 15(3): 350-7, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21735089
8.
Elevated incidence of sleep apnoea in acromegaly-correlation to disease activity.
Sleep Breath
; 16(4): 1247-53, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-22241151
9.
Endogenous estradiol may influence IGF-I levels in acromegalic women treated with pegvisomant.
Pituitary
; 13(1): 89-93, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-18498055
10.
Adverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care population.
Pituitary
; 13(3): 207-14, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20131100
11.
Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German Acromegaly Registry.
Eur J Endocrinol
; 182(3): 275-284, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31917680
12.
Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study.
Pituitary
; 12(3): 177-85, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-18836838
13.
Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial.
Endocrine
; 57(1): 156-165, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28597198
14.
Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly.
Eur J Endocrinol
; 155(1): 73-8, 2006 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-16793952
15.
Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel).
Exp Clin Endocrinol Diabetes
; 113(3): 139-44, 2005 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-15789272
16.
Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly.
Exp Clin Endocrinol Diabetes
; 113(4): 219-24, 2005 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-15891958
17.
Diagnostic use of facial image analysis software in endocrine and genetic disorders: review, current results and future perspectives.
Eur J Endocrinol
; 173(4): M39-44, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26162404
18.
Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
J Clin Endocrinol Metab
; 67(6): 1186-9, 1988 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-2903866
19.
Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood.
J Clin Endocrinol Metab
; 80(2): 552-7, 1995 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-7852519
20.
The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
J Clin Endocrinol Metab
; 81(5): 1994-8, 1996 May.
Artigo
Inglês
| MEDLINE | ID: mdl-8626871